熱門(mén)詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
瑞士EffRx Pharmaceuticals
EffRx Pharmaceuticals SA是一家從事藥物釋放的公司,總部位于瑞士Freienbach。該公司利用其不同的泡騰實(shí)施創(chuàng)新技術(shù),專(zhuān)長(zhǎng)于改進(jìn)現(xiàn)有的高容量藥物產(chǎn)品。EffRx的主要工作重心放在代謝性骨病、腫瘤支持治療、兒童用藥領(lǐng)域,并為大型生命周期管理(Life Cycle Management)公司提供支持。
EffRx已與Takeda旗下的奈科明公司(Nycomed)達(dá)成授權(quán)協(xié)議,在除美國(guó)、加拿大和日本之外的全球范圍開(kāi)發(fā)、制造和商業(yè)化EffRx用于治療骨質(zhì)疏松的專(zhuān)利泡騰阿侖膦酸鈉。
EffRx Pharmaceuticals SA is a drug delivery company based in Freienbach, Switzerland. EffRx specializes in improving existing high volume pharmaceutical products by utilizing its novel techniques in different effervescent executions. The primary focus of EffRx is in metabolic bone disease, oncology supportive care, pediatric medications and support to larger companies in Life Cycle Management.
EffRx has a licensing agreement with Nycomed, a Takeda Company, for development, manufacturing and commercialization of EffRx patented effervescent alendronate for the treatment of osteoporosis in all territories in the world except USA, Canada and Japan.